DataMeds AI, Inc. Business Acquisition, Pro Forma Revenue
DataMeds AI, Inc. (MEDS) reported Business Acquisition, Pro Forma Revenue of $7.97 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-12.
Financial Statements › Income Statement › Other Income
us-gaap:BusinessAcquisitionsProFormaRevenue · last filed 2025-05-12
- DataMeds AI, Inc. business acquisition, pro forma revenue for the quarter ending 2025-03-31 was $7.97M.
- DataMeds AI, Inc. business acquisition, pro forma revenue for fiscal 2024 was $45.75M, a 32.78% increase from fiscal 2023.
- DataMeds AI, Inc. business acquisition, pro forma revenue for fiscal 2023 was $34.45M.
| Period end | Business Acquisition, Pro Forma Revenue 3 month | Business Acquisition, Pro Forma Revenue 12 month |
|---|---|---|
| 2025-03-31 | $7.97M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $45.75M 10-K · filed 2025-03-25 | |
| 2023-12-31 | $34.45M 10-K · filed 2025-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |